Workflow
Barclays(BCS)
icon
Search documents
Barclays' Q3 Earnings Jump on Solid IB, Stock Up on Uptick in NII Target
ZACKS· 2024-10-24 13:46
Barclays’ (BCS) third-quarter 2024 net income attributable to ordinary equity holders of £1.56 billion ($2.03 billion) grew 23% year over year.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Shares of BCS on NYSE gained 4% in pre-market trading as profit increased. Investors also cheered an upward tweak in net interest income (NII) 2024 guidance.An increase in revenues (driven by solid investment banking performance), stable operating expenses (showing the success of cost-efficiency ...
Barclays profit jumps 23% in third quarter, beating expectations
CNBC· 2024-10-24 06:11
LONDON — British bank Barclays on Thursday reported £1.6 billion ($2 billion) net profit attributable to shareholders for the third quarter, beating expectations.The result compared with the £1.17 billion net profit forecast in an LSEG poll of analysts, and was 23% higher than the same period in 2023.Revenue for the period came in at £6.5 billion, slightly ahead of a forecast of £6.39 billion.The lender's return on tangible equity rose to 12.3% from 9.9% in the second quarter, as its CET1 ratio — a measure ...
Barclays to Become Exclusive Issuer of General Motors Credit Cards
PYMNTS.com· 2024-10-14 17:35
Barclays US Consumer Bank will become the exclusive issuer of General Motors' GM Rewards Mastercard and GM Business Mastercard in the United States in the summer of 2025 and will acquire the card program's receivables from the current issuer — Goldman Sachs — next year. The bank and the automaker announced their new long-term partnership agreement in a Monday (Oct. 14) press release. "As a leading and experienced player in the U.S. partner card market with a winning formula for growing partner programs, we ...
CVS Health Positioned For Medicare Margin Expansion And Market Share Gains, Says Barclays Analyst
Benzinga· 2024-10-10 18:41
Barclays upgraded CVS Health Inc CVS on higher Pharmacy & Consumer Wellness (PCW) estimates as headwinds are offset by share gains, with further upside potential from CostVantage.Despite macroeconomic pressures impacting the retail pharmacy sector, the analyst writes that CVS has shown resilience thanks to its diversified business model.Also Read: CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit.This has allowed the company to mitigate some of these challenges and c ...
Robinhood Stock Soars on Investor Day News, Barclays Note
Investopedia· 2024-10-08 18:55
Key TakeawaysRobinhood Markets announced it would hold its first investor day on Dec. 4.Barclays raised its price target on the stock as the analysts see momentum in the business likely to continue.Shares of Robinhood have almost doubled in 2024. Robinhood Markets (HOOD) shares jumped Tuesday after the online trading platform announced its first investor day, and Barclays gave a positive view of the company in its third-quarter outlook for the brokerage industry. Robinhood said the investor day would be hel ...
Jeep Parent Stellantis Posts Big Drop in US Sales, Gets Downgrade From Barclays
Investopedia· 2024-10-03 18:10
Key TakeawaysStellantis reported U.S. sales slumped 20% year-over-year in the third quarter as all of its brands except Fiat posted declines.The automaker will continue to offer incentives begun in the beginning of the quarter through the rest of the year.Barclays analysts downgraded the stock, saying they see no sign of recovery until the first half of next year at the earliest. Stellantis (STLA) shares fell Thursday after the automaker's U.S. unit reported a big drop in sales as all but one of its brands ...
Perimeter Announces Completion of Patient Enrollment in Pivotal Clinical Trial Evaluating OCT B-Series with ImgAssist AI in Breast-Conserving Surgeries
Prnewswire· 2024-10-01 20:15
– Perimeter OCT B-Series is the first system designed to combine AI with optical coherence tomography for margin assessment, with the aim of reducing the unacceptably high reoperation rates associated with BCS –– Recent study1 published in the Annals of Surgical Oncology revealed reoperation rates of 21.1% among commercially insured women and 14.9% among the Medicare cohort –– Primary endpoint results from OCT B-Series pivotal trial expected in Q4-2024; could support submission to FDA in 2025 –– First-ever ...
BCS vs. NRDBY: Which Stock Should Value Investors Buy Now?
ZACKS· 2024-09-17 16:41
Investors interested in stocks from the Banks - Foreign sector have probably already heard of Barclays (BCS) and Nordea Bank AB (NRDBY) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank is a proven strategy that target ...
Should Value Investors Buy Barclays (BCS) Stock?
ZACKS· 2024-09-17 14:46
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they bel ...
3 Financial Stocks to Buy in the Current Environment
ZACKS· 2024-09-17 13:20
To control inflation, the Fed raised interest rates for 10 straight policy meetings before finally opting for a rate pause in June 2023. It barely raised rates till the end of 2023 and promised at least three rate cuts in 2024. However, it is only in September of this year that we are finally going to see the first slashing of rates.Fed Chair Jerome Powell has continued to suggest that he is fairly certain of rate cuts this year, but the Fed would embark on that journey only after reviewing further data. Fr ...